A group of Pennsylvania healthcare providers, including Temple Health and Penn State Health, opted out of a $2.8 billion Blue Cross Blue Shield (BCBS) antitrust settlement and filed their own lawsuit. The plaintiffs, consisting of hospitals, clinics, and physician groups, submitted their case to the U.S. District Court for the Eastern District of Pennsylvania before the March 4 opt-out deadline. Similar lawsuits were also filed in California and Illinois. The lawsuit alleges that BCBS violated antitrust laws by illegally dividing the U.S. into exclusive “Service Areas” and restricting competition. The plaintiffs claim this practice resulted in lower payments for healthcare services than in a competitive market. They seek damages and other legal remedies under the Sherman Act.
The lawsuit highlights two key rules BCBS allegedly used to limit competition: the “National Best Efforts Rule,” which restricts non-BCBS revenue for insurers, and the “Local Best Efforts Rule,” which mandates that at least 80% of revenue in a service area comes from BCBS-branded services. BCBS has denied any wrongdoing but previously agreed to operational changes and a financial settlement to resolve the class-action claims. The outcome of these new lawsuits could have significant implications for healthcare providers and insurance competition.
